ValiRx (LON:VAL) Issues Quarterly Earnings Results

ValiRx (LON:VAL – Get Free Report) posted its quarterly earnings data on Monday. The company reported GBX (0.54) earnings per share (EPS) for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 3 million during the quarter. ValiRx had a negative return on equity of 45.91% and a negative net margin of 3,582.56%.

ValiRx Stock Down 0.6%

Shares of ValiRx stock opened at GBX 0.18 on Monday. The company has a 50-day simple moving average of GBX 0.23 and a two-hundred day simple moving average of GBX 0.30. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.27 and a current ratio of 9.66. ValiRx has a 52-week low of GBX 0.16 and a 52-week high of GBX 0.85. The stock has a market capitalization of £1.33 million, a PE ratio of -0.19 and a beta of 0.59.

About ValiRx

(Get Free Report)

ValiRx accelerates the development of treatments in cancer and women’s health to improve patient lives. We provide the scientific, financial and commercial framework to enable the rapid translation of innovative science into clinical development.

Recommended Stories

• Five stocks we like better than ValiRx
• SpaceX’s Historic IPO Has Already Sparked a 2X ETF Frenzy
• Cheesecake Factory Stock Is Up Over 50%—Is There Room for More CAKE?
• Royal Caribbean’s Best Quarter Ever Still Leaves a Big Question
• Lululemon’s China Backlash May Be Hiding a Bigger Valuation Story